Literature DB >> 23636469

Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.

Jaime Uribarri1, Weijing Cai, Renata Pyzik, Susan Goodman, Xue Chen, Li Zhu, Maya Ramdas, Gary E Striker, Helen Vlassara.   

Abstract

SIRT1 and PPARγ, host defenses regulating inflammation and metabolic functions, are suppressed under chronic high oxidant stress and inflammation (OS/Infl) conditions. In diabetes, dietary advanced glycation end products (dAGEs) cause OS/Infl and suppress SIRT1. Herein, we ask whether dAGEs also suppress host defense in adults without diabetes. The relationships between dAGEs and basal SIRT1 mRNA, PPARγ protein levels in mononuclear cells (MNC) and circulating inflammatory/metabolic markers were examined in 67 healthy adults aged >60 years and in 18 subjects, before and after random assignment to either a standard diet (regular >15 AGE Eq/day) or an isocaloric AGE-restricted diet (<10 AGE Eq/day) for 4 months. Also, the interactions of AGEs and anti-AGE receptor-1 (AGER1) with SIRT1 and PPARγ were assessed in wild type (WT) and AGER1-transduced (AGER1(+)) MNC-like THP-1 cells. We found that dAGE, but not caloric intake, correlated negatively with MNC SIRT1 mRNA levels and positively with circulating AGEs (sAGEs), OS/infl, MNC TNFα and RAGE. Basal MNC PPARγ protein was also lower in consumers of regular vs. AGE-restricted diet. AGE restriction restored MNC SIRT1 and PPARγ, and significantly decreased sAGEs, 8-isoprostanes, VCAM-1, MNC TNFα and RAGE. Model AGEs suppressed SIRT1 protein and activity, and PPARγ protein in WT, but not in AGER1(+) cells in vitro. In conclusion, chronic consumption of high-AGE diets depletes defenses such as SIRT1 and PPARγ, independent of calories, predisposing to OS/Infl and chronic metabolic disease. Restricted entry of oral AGEs may offer a disease-prevention alternative for healthy adults.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636469      PMCID: PMC3795943          DOI: 10.1007/s00726-013-1502-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  29 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.

Authors:  A Chawla; Y Barak; L Nagy; D Liao; P Tontonoz; R M Evans
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

3.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Authors:  Helen Vlassara; Weijing Cai; Jill Crandall; Teresia Goldberg; Robert Oberstein; Veronique Dardaine; Melpomeni Peppa; Elliot J Rayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

4.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Weijing Cai; Teresia Goldberg; Min Lu; Cijiang He; Helen Vlassara
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

5.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Authors:  Weijing Cai; Maya Ramdas; Li Zhu; Xue Chen; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

Review 6.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice.

Authors:  Reigh-Yi Lin; Ernane D Reis; Anthony T Dore; Min Lu; Newsha Ghodsi; John T Fallon; Edward A Fisher; Helen Vlassara
Journal:  Atherosclerosis       Date:  2002-08       Impact factor: 5.162

8.  Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.

Authors:  Feng Zheng; Cijiang He; Weijing Cai; Masakazu Hattori; Michael Steffes; Helen Vlassara
Journal:  Diabetes Metab Res Rev       Date:  2002 May-Jun       Impact factor: 4.876

9.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

Authors:  Susanna M Hofmann; Heng-Jiang Dong; Zhu Li; Weijing Cai; Jennifer Altomonte; Swan N Thung; Feng Zeng; Edward A Fisher; Helen Vlassara
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction.

Authors:  Weijing Cai; Qiao-Di Gao; Li Zhu; Melpomeni Peppa; Cijiang He; Helen Vlassara
Journal:  Mol Med       Date:  2002-07       Impact factor: 6.354

View more
  22 in total

1.  Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.

Authors:  Weijing Cai; Jaime Uribarri; Li Zhu; Xue Chen; Shobha Swamy; Zhengshan Zhao; Fabrizio Grosjean; Calogera Simonaro; George A Kuchel; Michal Schnaider-Beeri; Mark Woodward; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 2.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

3.  Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

Authors:  Jaime Uribarri; Weijing Cai; Mark Woodward; Elizabeth Tripp; Laurie Goldberg; Renata Pyzik; Kalle Yee; Laurie Tansman; Xue Chen; Venkatesh Mani; Zahi A Fayad; Helen Vlassara
Journal:  J Clin Endocrinol Metab       Date:  2015-02-19       Impact factor: 5.958

4.  A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms).

Authors:  Mona S Calvo; Anita Mehrotra; Robert B Beelman; Girish Nadkarni; Lingzhi Wang; Weijing Cai; Boon Cher Goh; Michael D Kalaras; Jaime Uribarri
Journal:  Plant Foods Hum Nutr       Date:  2016-09       Impact factor: 3.921

5.  Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Authors:  Helen Vlassara; Weijing Cai; Elizabeth Tripp; Renata Pyzik; Kalle Yee; Laurie Goldberg; Laurie Tansman; Xue Chen; Venkatesh Mani; Zahi A Fayad; Girish N Nadkarni; Gary E Striker; John C He; Jaime Uribarri
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

6.  Endogenous secretory RAGE increases with improvements in body composition and is associated with markers of adipocyte health.

Authors:  E R Miranda; K N Z Fuller; R K Perkins; C M Kroeger; J F Trepanowski; K A Varady; J M Haus
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-08-02       Impact factor: 4.222

7.  Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).

Authors:  Omonefe O Omofuma; David P Turner; Lindsay L Peterson; Anwar T Merchant; Jiajia Zhang; Susan E Steck
Journal:  Cancer Prev Res (Phila)       Date:  2020-03-13

Review 8.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

9.  Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury.

Authors:  Rong Gao; Jiao Chen; Yuxin Hu; Zhenyu Li; Shuxia Wang; Sreerama Shetty; Jian Fu
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

Review 10.  Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials.

Authors:  Rachel E Clarke; Aimee L Dordevic; Sih Min Tan; Lisa Ryan; Melinda T Coughlan
Journal:  Nutrients       Date:  2016-03-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.